(Registrieren)

Craig Broderick Appointed to Bank of Montreal Board of Directors

Geschrieben am 28-08-2018

Toronto (ots/PRNewswire) -

Bank of Montreal today announced the appointment of Craig
Broderick, former Chief Risk Officer of The Goldman Sachs Group,
Inc., to its Board of Directors.

"We are pleased to welcome Craig to the Board of Directors," said
J. Robert S. Prichard, Chairman of the Board. "He has a wealth of
knowledge and experience in financial services and deep expertise in
risk management and he will be a terrific addition to our Board."

Mr. Broderick retired from Goldman Sachs in January, 2018 after 32
years, having served most recently as the firm's Chief Risk Officer
from 2008-2018. He was a member of Goldman's Management Committee and
chair or co-chair of Goldman's most senior risk committees. At the
time of his retirement, Mr. Broderick was the longest serving chief
risk officer on Wall Street among the major institutions.

Mr. Broderick holds a BA (Econ) from The College of William and
Mary, in Virginia, and has been active with his alma mater including
serving for eight years until 2017 as a Trustee, and as chair of its
Investment Committee.

About BMO Financial Group

Serving customers for 200 years and counting, BMO is a highly
diversified financial services provider - the 8th largest bank, by
assets, in North America. With total assets of $765 billion as of
July 31, 2018, and a team of diverse and highly engaged employees,
BMO provides a broad range of personal and commercial banking, wealth
management and investment banking products and services to more than
12 million customers and conducts business through three operating
groups: Personal and Commercial Banking, BMO Wealth Management and
BMO Capital Markets.

Media Contacts: Paul Gammal, Toronto, paul.gammal@bmo.com,
+1-416-867-3996

ots Originaltext: BMO Financial Group
Im Internet recherchierbar: http://www.presseportal.de

Original-Content von: BMO Financial Group, übermittelt durch news aktuell


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

651552

weitere Artikel:
  • BMO Financial Group Declares Dividends Toronto (ots/PRNewswire) - Bank of Montreal (TSX:BMO) (NYSE:BMO) today announced that its Board of Directors declared a quarterly dividend of $0.96 per share on paid-up common shares of Bank of Montreal for the fourth quarter of fiscal year 2018 ("Q4 2018 Dividend"), unchanged from the previous quarter and up 7 per cent from the prior year. The Board of Directors also declared dividends of: - $0.112813 per share on paid-up Class B Preferred Shares Series 25; - $0.163332 per share on paid-up Class B Preferred Shares Series mehr...

  • BMO Financial Group Reports Third Quarter 2018 Results Toronto (ots/PRNewswire) - Financial Results Highlights Third Quarter 2018 Compared With Third Quarter 2017: - Net income of $1,536 million, up 11%; adjusted net income[1] of $1,565 million, up 14% - EPS[2] of $2.31, up 13%; adjusted EPS[1],[2 ]of $2.36, up 16% - ROE of 14.7%, up from 13.4%; adjusted ROE[1] of 15.0%, up from 13.3% - Provision for credit losses[3] (PCL) of $186 million compared with $202 million on an adjusted basis in the prior year and $126 million on a reported basis; prior year reported provision mehr...

  • Real-world Evidence From GARFIELD-AF Shows Superior Reduction in Mortality With Non-vitamin K Antagonists Oral Anticoagulants (NOACs) vs. Vitamin K Antagonists (VKAs) in Newly Diagnosed Atrial Fibrill Munich (ots/PRNewswire) - - High-risk patients on anticoagulants (AC) for stroke prevention also have 17% fewer deaths over 2 years of follow-up than patients who are not treated with AC - Patients who receive AC plus add-on antiplatelet therapy (AP) for stroke prevention have a significantly worse prognosis than patients on AC alone - More than 70% of patients on NOACs receive the recommended dose, but prescription of non-recommended doses is associated with a 51% increased risk of death - A mehr...

  • Alpbacher Wirtschaftsgespräche eröffnet Mehr Teilnehmer, rund 40 Partner, 30 Diskussionen und Breakout-Sessions bis 30. August Alpbach (ots) - In den nächsten Tagen untersuchen die Teilnehmerinnen und Teilnehmer der Alpbacher Wirtschaftsgespräche in über dreißig Diskussionen und Breakoutsessions das Spannungsfeld Diversität und Resilienz. Der Programmschwerpunkt liegt auf Datenökonomie und Diversität als Treiber von Innovation. "Die digitale Wirtschaft beeinflusst jeden Teil des Lebens", so Claus J. Raidl, Vizepräsident des Europäischen Forums Alpbach. Dies wolle man in mehr...

  • MARC O'POLO feiert großes Event in Shanghai (FOTO) Stephanskirchen / Shanghai (ots) - Gemeinsam mit dem chinesischen Master Franchise Partner lud die Premium Modern Casual Marke zu "O'ne Day with MARC O'POLO" in die exklusive Shopping Mall Taikoo Hui in Shanghai, in der MARC O'POLO seit April 2017 mit einem Store vertreten ist. Im Beisein des CEO des Franchise Partners, des MARC O'POLO Director Sales International, des CEO von Taikoo Hui sowie zahlreicher chinesischer VIP-Gäste, Key Opinion Leaders und rund 100 Medienvertretern wurden die Kollaboration und die Kampagne mit Julian mehr...

Mehr zu dem Thema Aktuelle Wirtschaftsnews

Der meistgelesene Artikel zu dem Thema:

DBV löst Berechtigungsscheine von knapp 344 Mio. EUR ein

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht